Kriba
Non-invasive screening and monitoring of serous fluids infections of the body.
- B2B
- manufacturing
- commission
- health
- medical devices
- biotechnology
- artificial intelligence
- deep tech
- machine learning
- computer vision
- connected device
- biotechnology
- horizon europe
- dt and ls
- spinout
- core ai
- ai applications
- eit ecosystem
- predictive analytics
- cardiology and cardiovascular
- eit health
- non-invasive medical devices and treatments
- health it
- physician support tools
- health diagnostics
- eicfund
- 4yfn 2025
- medical diagnostics
- medical imaging
- clinical decision support
- headstart (eit health)
- health information
- european health catapult (eit health)
- mentoring and coaching network (eit health)
- mentoring and coaching network 2019 (eit health)
- pediatrics
- headstart 2018 (eit health)
- living labs and test beds (eit health)
- european health catapult 2020 (eit health)
- living labs and test beds 2019 (eit health)
- digital sandbox (eit health)
- digital sandbox 2019 (eit health)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | €2.5m | Grant | |
| Total Funding | 000k | ||
| EUR | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | (22 %) | (79 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | 64 % | 48 % | (300 %) |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | 48 % | 24 % | (422 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
More about Kriba
EditKriba® is a medical device startup aiming at globally democratizing non-invasive, quick, easy and cost-efficient screening and monitoring of potentially life-threatening extravascular serous fluids infections like infant meningitis, peritoneal dialysis-associated peritonitis, anterior uveitis, among others. Located in the Barcelona Science Park in Spain, Kriba has developed Neosonics® and Neosonics® Vitro Kidney, an AI-powered ultrasound device for quick and rapid screening and monitoring of serous fluids infections.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.